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Abstract
Background: Gastrointestinal stromal tumours (GISTs) are uncommon primary mesenchymal
tumours of the gastrointestinal tract mostly observed in the adults. Duodenal GISTs are relatively
rare in adults and it should be regarded as exceptional in childhood. In young patients duodenal
GISTs may be a source of potentially lethal haemorrhage and this adds diagnostic and therapeutic
dilemmas to the concern about the long-term outcome.
Case presentation: A 14-year-old boy was referred to our hospital with severe anaemia due to
recurrent episodes of upper gastrointestinal haemorrhage. Endoscopy, small bowel series,
scintigraphy and video capsule endoscopy previously done elsewhere were negative. Shortly after
the admission, the patient underwent emergency surgery for severe recurrence of the bleeding. At
surgery, a 4 cm solid mass arising from the wall of the fourth portion of the duodenum was
identified. The invasion and the erosion of the duodenal mucosa was confirmed by intra-operative
pushed duodenoscopy. The mass was resected by a full-thickness duodenal wall excision with
adequate grossly free margins. Immunohistochemical analysis of the specimen revealed to be
positive for CD117 (c-KIT protein) consistent with a diagnosis of GIST. The number of mitoses
was < 5/50 HPF. Mutational analysis for c-KIT/PDGFRA tyrosine kinase receptor genes resulted in
a wildtype pattern. The patient had an uneventful course and he has remained disease-free during
two years of follow-up.
Conclusion: Duodenal GISTs in children are very rare and may present with massive bleeding.
Cure can be achieved by complete surgical resection, but even in the low-aggressive tumours the
long-term outcome may be unpredictable.
Background
Gastrointestinal stromal tumours (GISTs) are uncommon
mesenchymal tumours of the gastro-intestinal tract (GI)
believed to originate from the interstitial cells of Cajal
(ICC) [1]. Likewise ICC, the GIST cells carry the receptor
tyrosine kinase (KIT). Immunohistochemically the spe-
cific marker for KIT (CD117) is used to distinguish GIST
from others spindle-cell tumours of the GI. Although a
GIST may arise anywhere in the GI, stomach and small
bowel are the most elective sites [2]. It can be estimated
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account approximately to 5% [3-5]. GISTs are far more
common in adults, and over the age of 40. A report
focused on the epidemiology of GISTs and including
1,458 cases found no patient below the age of 20 [6]. Oth-
ers large sample size retrospective studies confirm that
GISTs are mostly observed in adults and are rare in chil-
dren. Only 2.7% of GISTs of the stomach and 0.6% of
GISTs of the small-bowel occur before the age of 21 years
and the mean age of patients presenting with duodenal
GISTs is over 50 [3-5]. Duodenal GISTs in children are
extremely rare. We report a new clinical observation to
enforce knowledge about GISTs of the duodenum in
young patients.
Case presentation
A 14 year-old boy was referred to the emergency depart-
ment for severe episodes of upper gastrointestinal bleed-
ing, the first of whom dated back to one year. A few days
before, the patient had been admitted elsewhere for
melena, tachycardia, mild hypo-tension and severe anae-
mia (Hb7.5 g/dl). At that time, after blood volume
replacement, the patient underwent upper and lower
endoscopy studies, abdominal ultrasound (US) scan,
pertecnate 99 m (Tc99m) scintigraphy and video-capsule
enteroscopy, all of which resulted negative. The patient re-
bled severely shortly after his arrival at the emergency
department and surgery was warranted. At laparotomy
there was fresh blood into the jejunum and ileum but not
into the stomach. Exposure of the duodenum by extended
Kocher's manoeuvre and Treitz's ligament take-down,
allowed the detection of a roundish solid mass, 4 cm. in
diameter, arising from the pancreatic border of the fourth
portion of the duodenum. The mass, mostly esophytic,
did not invade the pancreatic body (Figure 1).
Intra-operative pushed upper endoscopy was performed.
At endoscopy, the tumour protruded into the lumen and
centrally ulcerated the mucosa. (Figure 2) A mild ongoing
haemorrhage from the erosion was seen.
The duodenal wall was carefully dissected free from the
lower pancreatic border and from the superior mesenteric
artery. Removal of the mass was then accomplished by a
full-thickness excision of the anterior duodenal wall with
adequate grossly free margins. The duodenal defect was
over-sewn and covered by an omental patch.
Histopathologic report revealed the tumour was com-
posed by epithelioid and spindle cells (Figure 3), with a
mitotic activity < 5 per 50 high power field (HPF). The
tumour stained positive for CD117 (Figure 4), CD34 and
smooth muscle actine and negative for S100 protein, CK-
pan, CD45-LCA, and melanosome, consistent with the
diagnosis of GIST. Genomic DNA was isolated from par-
affin-embedded tumor tissue. Molecular work-up based
on polymerase chain amplification followed by direct
sequence analysis of selected coding sequences of KIT
(exons 9,11, and 13) and platelet-derived growth factor
receptor α (PDGFRα; exons 12,14, and 18) yielded no evi-
dence of mutation. As diagnosis of GIST was made, the
patient was investigated to detect clinical features of type
1 neurofibromatosis and of Carney's triad (GIST associ-
ated with paraganglioma and pulmonary chondroma).
Both syndromes were excluded. In addition, no other
family members resulted affected by GIST. The course was
uneventful and the patient has remained asymptomatic
with no local or distant recurrence at the two years follow-
up. No program of imatinib mesylate chemotherapy was
undertaken.
Conclusion
Most GISTs arise in adults over 40 years of age [6]. In the
pediatric age group, GISTs occur in the sporadic form and
in some cases are associated with Carney's triad or type 1
neurofibromatosis. Rare cases of familial GISts which
carry a KIT or PDGFRa germline mutation have been also
described [7,8]. The duodenal localization of a GIST in
children is however exceptional. Cypriano and Coll. [9]
reported in 2004 a series of 7 pediatric patients affected by
GIST: none of them originated from the duodenum. More
recently, from a review of the English-language biomedi-
cal literature, Hayashi & Coll.[10] found 25 children
affected by GIST, none of them with a duodenal localiza-
tion. Two further series of pediatric GISTs, each collecting
five cases, failed to identify a duodenal localization
[11,12]. So far, the only previously described pediatric
patient with a duodenal GIST is by Towu and Coll. that
reported in two papers the case of a 7-year-old boy: bleed-
ing was the clinical presentation and the tumour was suc-
cessfully resected [13,14]. Likewise in adults, duodenal
GISTs in children may have an acute clinical onset, with
bleeding as one of the most common complication.
Endo-luminal bleeding is the expression of local invasion
and erosion of the GI mucosa. For GISTs of the foregut,
the identification of the source of bleeding may be easily
performed by upper endoscopy whenever the tumor is
located in the stomach or in the upper duodenum. On the
other hand GISTs of the distal duodenum may remain
undetected at endoscopy. Alternative diagnostic means
for occult upper GI bleeding include duodenum series, US
and computed tomography, video-capsule endoscopy,
Tc99m scintigraphy and angiography. In the presented
cases most of them resulted un-effective in making the
diagnosis that was cleared only at surgery. Surgical
removal of a duodenal GIST may be accomplished by sev-
eral options, ranging from the minimal to outmost
demolitive procedures. Local tumour excision [15], seg-
mental duodenal resection [16-18] and pancreatoduo-
denectomy [19-21] have all been advocated, dependingPage 2 of 5
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rounding organs invasion. Total tumour resection is the
standard of cure for GISTs. Nodes dissection is not recom-
mended, because GISTs rarely metastasize to lymph nodes
[22]. In eligible patients, total resection of a duodenal
GIST can be achieved by a simple excision procedure, that
is effective in controlling the bleeding and in achieving
cure. Children may benefit of advantages from lesser
demolitive duodenal surgery. Treatment with imatinib, an
inhibitor of receptor tyrosine kinases (RTKs), may be
offered to pediatric patients with advanced GIST disease,
not radically amenable by surgery. Several papers have
reported a correlation between the nature of molecular
alterations of KIT and PDGFRα and response to imatinib
treatment [23-25]. In adults most GISTs are caused by
mutations in the KIT or PDGFRα receptor tyrosine kinase
genes and this make them amenable to therapy with imat-
inib. Thus, adult patients with unresectable or recurrent
GIST have a better prognosis because the disease usually
responds to therapy. In children genes mutations have
been described in the rare cases of familial GISTs, but they
do occur very rarely in sporadic GISTs [11,12,26]. Because
most pediatric GISTs have KIT/PDGFRα wildtype pat-
GIST cells stained positive for CD117(c-KIT) (magnification, × 20)Figure 4
GIST cells stained positive for CD117(c-KIT) (magnification, 
× 20).
Intra-operative push-endoscopy: GIST protusion into the duodenal lum n with mucosa ulceratedFigure 2
Intra-operative push-endoscopy: GIST protusion into the 
duodenal lumen with mucosa ulcerated.
Operative view: esophytic GIST of the fourth duodenal por-tionFigure 1
Operative view: esophytic GIST of the fourth duodenal por-
tion.
Microscopic appearance of the duodenal GIST demonstrating epithelioid and spindle cells (H&E; magnification, ×10)Figure 3
Microscopic appearance of the duodenal GIST demonstrating 
epithelioid and spindle cells (H&E; magnification, ×10).Page 3 of 5
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treatment less well than adults do.
Complete surgical resection of GISTs seems however more
likely in pediatric rather than in adult patients. In a paper
presenting a series of pediatric patients with GIST and col-
lecting data from literature, the rate of complete surgical
resection was 80% (18 out 23 patients) and more than
90% of these patients survived with no evidence of recur-
rence [9]. In adults, complete surgical resection of GISTs
has been reported in 40% of cases [27]. Moreover the
recurrence of GISTs in adults ranges from 40 to 80%
despite complete surgical resection of the primary tumor
[22,27]. These data suggest a more benign course for pedi-
atric GISTs respect to adult cases.
According to the risk assessment criteria [2], the GIST of
the presented case fell in to the low-risk of aggressive
behaviour category (tumour size < 5 cm and mitotic
counts < 5 mitotic figures per 50 HPF) and no chemother-
apy after surgery was offered. Miettinen & Coll. [4] in a
review of 156 duodenal GIST including adult and pediat-
ric patients, found that 86% of those with a tumour > 5
cm with > 5 mitoses per 50 HPF died of disease, whereas
no recurrence or metastases were seen in patients with
tumour < 2 cm with < 5 mitoses/50 HPF. However, they
occasionally observed the development of metastases
even if the mitotic activity was < 5/50 HPF and the tumour
size was < 5 cm. Thus, in young patients, even for the low-
aggressive category of totally resected duodenal GISTs, the
long-term outcome remains unpredictable. A long-term
follow-up study is strongly advisable.
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